RVSV HIV-1 gag vaccine: Phase I started

Profectus began a double-blind, placebo-controlled, dose-escalation, Phase I trial to evaluate its intramuscular recombinant vesicular stomatitis virus (rVSV) HIV-1 gag vaccine in 60 HIV uninfected pa...